Cross Border Taking Private Merger of SHL Telemedicine Ltd. (SIX: SHLTN)
27 July 2015 – On 24 July 2015, SHL Telemedicine Ltd, Tel Aviv (SHL), a company listed on the SIX Swiss Exchange, and Shanghai Jiuchuan Investment (Group) Co., Ltd, Shanghai (the Purchaser) have entered into a merger agreement, pursuant to which the Purchaser will, through one of its wholly owned subsidiary, acquire the entire share capital of SHL by way of a reverse triangular cross border merger. The transaction is subject to the approval by the shareholders' meetings. The closing is expected to occur in Q4 2015.
SHL is a leading provider and developer of advanced personal telemedicine solutions.
Walder Wyss advises SHL on all capital markets, stock exchange and takeover law aspects in this transaction. The team has been led by Alex Nikitine (Capital Markets, M&A, Partner) and furhter includes Sarah Schulthess (Capital Markets, M&A, Associate), Enrico Friz (Banking & Finance, Partner), Valentin Wiesner (Banking & Finance, Trainee), Anna-Lynn Fromer (Banking & Finance, Trainee), Tervel Stoyanov (Banking & Finance, Associate), Hubertus Hillerström (Banking & Finance, Managing Associate) and Janine Corti (Tax, Associate).